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The saliva microbiome profiles are 
minimally affected by collection 
method or DNA extraction 
protocols
Yenkai Lim1,2, Makrina Totsika  1, Mark Morrison3 & Chamindie Punyadeera  1,2
Saliva has attracted attention as a diagnostic fluid due to the association of oral microbiota with 
systemic diseases. However, the lack of standardised methods for saliva collection has led to the 
slow uptake of saliva in microbiome research. The aim of this study was to systematically evaluate 
the potential effects on salivary microbiome profiles using different methods of saliva collection, 
storage and gDNA extraction. Three types of saliva fractions were collected from healthy individuals 
with or without the gDNA stabilising buffer. Subsequently, three types of gDNA extraction methods 
were evaluated to determine the gDNA extraction efficiencies from saliva samples. The purity of total 
bacterial gDNA was evaluated using the ratio of human β-globin to bacterial 16S rRNA PCR while 
16S rRNA gene amplicon sequencing was carried out to identify the bacterial profiles present in these 
samples. The quantity and quality of extracted gDNA were similar among all three gDNA extraction 
methods and there were no statistically significant differences in the bacterial profiles among different 
saliva fractions at the genus-level of taxonomic classification. In conclusion, saliva sampling, processing 
and gDNA preparation do not have major influence on microbiome profiles.
As a biospecimen, saliva is less utilised in a Clinical Chemistry Laboratory compared to tissue, blood, urine and 
faecal matter despite being the most easily accessible non-invasive body fluid1. This is in part due to the lack of 
standardised saliva sample collection protocols and our limited knowledge about the diurnal variability of bio-
molecules in saliva2. Unlike other biospecimens, saliva sample types (whole-mouth unstimulated saliva, acid and 
mechanically stimulated saliva, oral swab and oral rinse) may differ in their composition and may have an impact 
on the analytes to be detected3. In addition, the relatively low abundance of biomolecules in saliva makes it more 
challenging albeit using advanced technologies4–7. To date, salivary biomarkers of potential diagnostic value has 
been identified and validated for both oral and systemic diseases8–15. Currently, salivary DNA based methods are 
used in many diagnostic laboratories for mutations and polymorphisms studies relating to cancers and hereditary 
disorders16.
The microbial communities resident at different sites of the human body are widely recognised for their roles 
in protecting, initiating, and facilitating disease pathogenesis, and the oral cavity is relatively understudied in this 
regard. Reliable characterisation of these microbial communities in various disease states should also support 
the development of new saliva-based diagnostics and therapeutics17–20. Historically, oral microbiota research has 
heavily depended on microbial specific cultures although many researchers adapted to cultivation-independent 
molecular techniques to more holistically assess microbiome (the collective genomes of microorganisms) 
changes21, 22. The advent of high-throughput genomic (g)DNA sequencing methods has revolutionized the field 
of human microbiome research, with particular focus to date on the gut microbiome using faecal samples.
In 2012, the International Human Microbiome Standards (IHMS) were concerned that the sample collec-
tion, processing and gDNA preparation of faecal samples may influence the data generated in human metagen-
omics research studies. Supported by the European Commission, a suite of sample collection and processing 
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procedures were tested and gDNA preparation was carried out by IHMS contributors across 12 different coun-
tries. Contributors were asked to extract gDNA from the provided faecal samples using their own laboratory 
procedures as well as other standard protocols from literatures. After a thorough investigation such as the gDNA 
yield, quality and recovery of diversity and specific bacterial taxa, a set of 14 standard operating procedures 
were designed to help optimise data quality and comparability in the human microbiome field (http://www.
microbiome-standards.org). As the next-stage forward, this study will investigate the influence of sample collec-
tion, processing and gDNA preparation with regards to saliva samples.
Aims of this study were three-fold: (i) to investigate the influence of saliva collection method on microbial 
analysis; (ii) to evaluate the most efficient bacterial gDNA extraction protocol from human saliva and; (iii) to 
determine the best saliva fraction for oral microbial studies. While different saliva collection methods are known 
to influence the composition of saliva biomolecules, we demonstrate that it does not contribute significantly to 
the oral microbiome profile. In addition, the overall bacterial gDNA yield was not affected by different extraction 
protocols when repeated bead-beating with lysis-buffer was implemented. However, the Maxwell® 16 LEV blood 
DNA kit was able to significantly increased the purity of the bacterial gDNA.
Methods and Materials
Study cohort and sample collection. This study was approved by the Queensland University of 
Technology (HREC no.: 1400000617) Medical Ethical Institutional Board and informed consent was obtained 
from all participants. All methods in this study were performed in accordance with the relevant guidelines and 
regulations. We have recruited normal healthy controls (n = 40) from the general population based on strin-
gent recruitment criteria (Supplementary Data 1) to minimise baseline variations that may potentially affect the 
experimental endpoints. All volunteers (between 20 to 30 years of age) were self-reported to be in good general 
health with no underlying diseases, not receiving local and/or systemic antibiotics and no history of smoking and 
drinking habits.
Volunteers were asked to refrain from eating and drinking for an hour prior to donating saliva samples as 
per our previous work9, 10, 12. The volunteers were asked to sit in a comfortable position and were asked to rinse 
their mouths with bottled water to remove food debris. A set of two spit saliva samples were collected from ten 
volunteers (total samples, n = 20) in a 50 mL sterile Falcon tube (Becton, Dickinson and Company, New Jersey, 
USA) and an OMNIgene tube (DNA Genotek Incorporation, Ontario, Canada), respectively. Spit samples were 
collected by asking volunteers to forcefully spit saliva (not sputum) directly into the saliva collection devices 
(OMNIgene includes a separate mouth-piece that can be connected to the devise for saliva spitting and drooling 
proposes) (Fig. 1a). OMNIgene contained 1 mL of stabilising buffer, hence the maximum saliva sample that can 
be collected is 1 mL (OMNIgene tube capacity is 2 mL). Since 200 μL of saliva sample is required per extraction, a 
1:1 mixture of spit sample collected from 50 mL sterile Falcon tube and 1 x phosphate-buffered saline (PBS) was 
used to have similar saliva sample volumes for microbial analysis.
Similarly three sets of saliva fractions were collected from a different cohort of 30 normal healthy volunteers 
(total samples, n = 90) in the order of spit, drool and oral rinse with five minute intervals. Drool samples were col-
lected by asking volunteers to pool saliva in the mouth and expectorate naturally into a 50 mL sterile Falcon tube 
while spit samples were collected as described above. Oral rinse samples were collected by asking volunteers to 
swish and gargle with 10 mL of 0.9% (w/v) saline solution (Baxter International Incorporate, Illinois, USA) for a 
Figure 1. Study design overview. From Fig. 1a, Maxwell® 16 LEV Blood Kit was found to be the most efficient 
bacterial gDNA extraction method when spit samples were collected in 50 mL sterile Falcon tube. Hence, 
OMNIgene and other salivary bacterial gDNA extraction methods were excluded from the second part of the 
study (Fig. 1b).
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minute and expectorate into a 50 mL sterile Falcon tube as previously published (Fig. 1b)8. We have also tested the 
reverse order of sample collection to ensure that the order of collection does not influence the microbial diversity.
After collection, all samples were transported back to the laboratory on dry ice. Spit and drool samples were 
aliquoted evenly into 1.5 mL Eppendorf tubes (Eppendorf, Hamburg, Germany) and stored at −80 °C. Oral rinse 
samples were further processed by centrifugation at 1000 × g for 15 minutes at 4 °C to separate the cellular pellet 
from cell-free salivary supernatant. Cellular pellets were resuspended in sterile 1 x PBS and aliquoted evenly into 
1.5 mL Eppendorf tubes and stored at −80 °C.
Maxwell® 16 LEV blood DNA kit. Saliva samples (200 μL irrespective of the fraction) were subjected to 
centrifugation at 16000 × g for 10 minutes at 4 °C (to reduce bacterial activities in saliva samples) to separate the 
cellular pellet from cell-free supernatant. A volume of 500 μL of in-house lysis buffer (200 mL of 0.5 M sodium 
chloride, 0.05 M trisaminomethane at pH8, 0.05 M ethylenediaminetetraacetic acid at pH 8 and 4% sodium dode-
cyl sulfate) was added to the cellular pellet and mixed well by vortexing. The samples were then transferred to a 
2 mL conical screw cap microtube with zirconimum beads (combination of 0.3 g of 0.1 mm and 0.1 g of 0.5 mm, 
Daintree Scientific, St. Helens, Tasmania, Australia) and the cells were disrupted using the Precellys® 24 (Bertin 
Corporation, Rockville, USA) at 5000 × g for 3 × 60 seconds. The homogenates were then incubated within a 
70 °C water-bath for 15 minutes with the contents mixed at five minute intervals by gentle inversion of the tubes. 
After incubation, samples were centrifuged at 15000 × g for five minutes and the supernatant fractions were 
transferred to sterile 1.5 mL Eppendorf tubes containing 30 μL of proteinase-K (Maxwell® 16 LEV blood DNA 
kit), vortexed for 30 seconds, then incubated at 56 °C for 20 minutes. Total nucleic acids were then recovered 
from these samples using the blood DNA columns using the Maxwell® 16 MDx Research Instrument (Promega 
Corporation, Wisconsin, USA). Finally, 2 μL of 10 μg RNase A (Qiagen, Hilden, Germany) was added to the sam-
ples and incubated in a 37 °C water-bath for 15 minutes for RNA digestion.
Phenol-chloroform method. The sample preparation and bacterial cell lysis for the phenol-chloroform 
extraction method was similar to the Maxwell® 16 LEV blood DNA method described above, with the follow-
ing modifications. After the second incubation in a 56 °C water-bath for 20 minutes, equal volumes of buffer 
saturated phenol (Sigma Co., Victoria, Australia) was added and mixed by inverting several times and centri-
fuged at 18000 × g for 5 minutes at 4 °C. The aqueous layer was carefully removed into a new 1.5 mL Eppendorf 
tube without disturbing the interphase layer. An equal volume of chloroform:isoamyl (24:1) alcohol (Sigma Co., 
Victoria, Australia) mixture was added to the sample and vortexed for 5 minutes for further purification. Mixed 
samples were centrifuged at 18000 × g for 10 minutes at 4 °C and the aqueous layer was transferred into a new 
1.5 mL Eppendorf tube. Depending on the volume of the aqueous layer, 1:10 of 3 M sodium acetate (pH 5.2) and 
an equal volume of 100% isopropanol were added to the sample and mixed well before incubating at −20 °C 
overnight. The samples were then centrifuged at 18000 × g for 10 minutes at 4 °C, the supernatant discarded and 
500 μL of 70% ethanol was added to the pellet before centrifugation again at 18000 × g for 5 minutes at 4 °C. The 
supernatant was discarded and the gDNA samples were dried using a SpeedVac Concentrator SAVANT ISS110 
(ThermoFisher Scientific, Massachusetts, USA) for 5 minutes at 60 °C. The gDNA was resuspended in 20 μL of 1 x 
trisaminomethane and ethylenediaminetetraacetic acid buffer and vortexed for a minute to mix well. Finally, 2 μL 
of 10 μg RNase A was added to the sample and incubated in a 37 °C water-bath for 15 minutes for RNA digestion.
QIAamp DNA Microbiome Kit. The sample preparation and bacterial cell lysis for the QIAamp DNA 
Microbiome Kit (Qiagen, Hilden, Germany) extraction method was similar to the Maxwell® 16 LEV blood DNA 
method. However, the proteinase K from QIAamp DNA microbiome kit was used for the second incubation. The 
QIAamp DNA microbiome kit extraction was carried out according to the manufacturers’ instruction and gDNA 
was eluted in a final volume of 50 μL. A volume of 2 μL of 10 μg RNase A was added to the gDNA sample and 
incubated in a 37 °C water-bath for 15 minutes for RNA digestion.
gDNA quantification. The quantity and quality of the extracted gDNA were evaluated using the Nano Drop 
ND-1000 spectrophotometer (ThermoFisher Scientific, Massachusetts, USA).
Quantitative PCR. Bacterial 16S rRNA primer set (1114F-5′ CGGCAACGAGCGCAACCC 3′ and 1221R-5′ 
CCATTGTAGCACGTGTGTAGCC 3′) and human β-globin primer set (F-5′ CAACTTCATCCACGTTCACC 3′ 
and R-5′ GAAGAGCCAAGGACAGGTAC 3′) were used in quantitative (q)PCR reactions to determine the ratio 
of bacteria to human gDNA from the extracted samples. The reaction consisted of 5 μL of 2 × iTaq™ Universal 
SYBR® Green Supermix (Bio-Rad Laboratories, California, USA), 200 nM of forward and reverse primers for 
each of the respective genes and 20 ng of gDNA template. The total reaction volume (10 μL) was subjected to 
qPCR amplification using the conditions of an initial denaturing stage at 95 °C for 10 minutes and followed by 30 
cycles of a minute at 60 °C. Escherichia coli gDNA was used as a positive control while DNase/RNase water was 
used as a negative control for the qPCR assay.
16S rRNA gene amplicon library preparation and sequencing. 16S rRNA gene amplicons for 
sequencing by Illumina MiSeq system (Illumina Incorporate, California, USA) was prepared according to the 
manufacturers’ method with gene-specific sequences targeting the V6 and V8 hypervariable regions of the 16S 
rRNA gene23. Q5® Hot Start High-Fidelity (New England Biolads, Masachusetts, USA) polymerase enzyme 
was used for the index PCR instead of the recommended KAPA HiFi HotStart ReadyMix (Kapa Biosystem, 
Massachusetts, USA) polymerase enzyme, as the former enzyme yielded superior amplification efficiency with a 
lower error rate. Sequencing was performed at the Australian Centre for Ecogenomics (ACE, Brisbane, Australia).
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Statistical analysis. The statistical analysis for the investigation of the influence of saliva collection devices 
and the efficiency of saliva gDNA extraction methods were carried out by using GraphPad Prism (GraphPad 
Software Incorporate, California, USA). Since the quantity and quality of the extracted gDNA were not normally 
distributed, the non-parametric Wilcoxon matched-pairs signed rank test was used when comparing two differ-
ent variables while the Friedman test was used when comparing more than two different variables. In addition, 
the Friedman test was also used to analyse the Ct mean variation of the bacterial 16S rRNA gene and the human 
β-globin gene of the gDNA extracted.
Illumina sequenced datasets were analysed using Quantitative Insights Into Microbial Ecology (QIIME) 
version 1.9.1 [PMID: 20383131] on the Ubuntu Linux virtual machine (Canonical Limited, London, United 
Kingdom). USEARCH 6.1 [PMID: 20709691] was used to perform a reference based chimera detection and 
removal to avoid perceived diversity24. Briefly, sequences were clustered into operational taxonomic units (OTUs) 
by PyNAST [PMID: 19914921] with a 97% sequence identity threshold against Greengenes core set database 
version 13.8 [PMID:16820507]25. An OTU table was generated with a list of prokaryotes and their respective 
observed OTU counts (abundance) for each sample based on the sequenced data in a biological observation 
matrix format. The OTU table was further edited to remove low abundance OTUs (≤0.1% of total sequences) 
and any sequences that were not of bacterial or archaeal origin. A subsampled OTU table was created by random 
sampling (without replacement) of the original OTU table based on the sample with the lowest OTU counts to 
account for different sequencing depths that may occur for each individual sample. The subsampled OTU table 
was used to calculate the α- (within-sample) and β- (between-sample) diversity metrics and to generate taxa sum-
maries for each saliva fraction, from the phylum to genus levels of classification. Shannon index was used as an 
estimator for richness and evenness of the microbial community. Distance between samples was represented by 
the weighted (quantitative) and unweighted (qualitative) UniFrac distance metrics [PMID: 16332807] which are 
presented via principal component analysis (PCoA) plotting. Calypso version 5.4 (http://cgenome.net:8080/html/
wiki/index.php/Calypso) was used to further analyse these data by providing statistical information on the sig-
nificance of distribution for each genus as well as the combined genera in the three saliva fractions. Since the dis-
tribution of the genera between each saliva fraction is non-parametric, the Kruskal-Wallis rank test was used on 
Calypso to identify any significant differences in genera distribution. According to the p-values generated, there 
are no significant differences in the distribution of genera in spit, drool and oral rinse (Supplementary Data 6).
Results
The quantity and quality of total gDNA extracted using different saliva collection and extrac-
tion methods. There were no significant differences in the quantity and quality of extracted gDNA in saliva 
samples collected from the first normal healthy control cohort (n = 10) (Fig. 1a), demonstrating the resilient of 
salivary gDNA without the help of additional preservation system (Fig. 2). The salivary gDNA extraction was per-
formed in triplicate and the results were consistent and reproducible (Supplementary Data 2). In contrast, the sal-
ivary gDNA quantity and quality significantly differed among the three extraction methods (Fig. 3). Irrespective 
of the collection method, the average gDNA quantity was high in spit samples using the Maxwell® 16 LEV blood 
DNA kit followed by the phenol-chloroform extraction method compared with a commercial QIAamp DNA 
Microbiome Kit method (Supplementary Data 3). However, the data were less variable when gDNA was extracted 
using the QIAamp DNA Microbiome Kit. In terms of gDNA quality, the 260/280 ratio of samples extracted with 
Maxwell® 16 LEV blood DNA kit were closer to the 1.8 ‘pure’ gDNA value. To ensure that the extracted gDNA is 
not contaminated with RNA, randomly selected gDNA samples were analysed on a 1% agarose gel electrophore-
sis. No RNA traces were detected by this analysis.
Purity of isolated bacterial gDNA from various saliva fractions. Since there were no significant 
differences in the quantity and quality of gDNA extracted from the triplicate extraction as described above for 
each sample, gDNA was pooled and used as template for qPCR assays to determine the ratio of bacterial to human 
gDNA content. The qPCR assays’ efficiency were optimised using six-point serial dilution from 1.56 to 50 ng for 
the bacterial 16S rRNA gene and the human β-globin gene. Based on the results, the qPCR showed an average 
PCR efficiency of 0.99 for the bacterial 16S rRNA gene and an average efficiency of 0.98 for the human β-globin 
gene (Supplementary Data 4).
All spit samples were screened under the optimised condition. According to the results, Maxwell® 16 LEV 
blood DNA kit appeared to be a better extraction method with spit sample collected in 50 mL sterile Falcon tubes. 
The average ratio of threshold cycle (Ct) mean between extracted bacterial to human gDNA from spit samples 
collected in 50 mL Falcon tube using Maxwell® 16 LEV blood DNA kit was highest (Ct, 16.48:28.35 respectively) 
with multiple undetectable Ct means for the human β-globin gene (Table 1). It was noted that although the human 
β-globin gene was mostly undetected in extracted gDNA from spit samples collected in OMNIgene using the 
Maxwell® 16 LEV blood DNA kit, the average Ct mean for the bacterial 16S rRNA gene was significantly higher 
at 22.51, indicating a low abundance of bacterial gDNA (Table 1).
Based on these collective results, the Maxwell® 16 LEV blood DNA kit appears to provide a more enriched 
bacterial gDNA extraction from our samples. The average Ct mean for the bacterial 16S rRNA gene from each 
extraction method did not significantly differ from one another while Maxwell® 16 LEV blood DNA kit was able 
to significantly reduce the content of human gDNA (Table 1). We also chose to collect samples in 50 mL sterile 
Falcon tubes and store at −80 °C for the second part of this study, in our hands, this collection method was more 
compatible with our subsequent use of the Maxwell® 16 LEV blood DNA kit.
The influence of saliva fraction on microbial analysis. From the second normal healthy control cohort 
(n = 30) (Fig. 1b), the quantity and quality of extracted gDNA were significantly different between saliva fractions 
(Fig. 4a). The purity of gDNA from the saliva fractions was determined using the 16S rRNA gene and the human 
www.nature.com/scientificreports/
5ScIenTIfIc RepoRts | 7: 8523  | DOI:10.1038/s41598-017-07885-3
β-globin gene qPCR assays as previously described. There were no significant differences between the purity of 
bacterial gDNA extracted from spit, drool and oral rinse (Fig. 4b).
Extracted gDNA from spit, drool and oral rinse samples from 10 randomly selected healthy individuals were 
subjected to 16S rRNA gene amplicon sequencing to compare the microbial diversity among different saliva 
fractions. Based on our data, the average length of reads is 500 bp and the OTU were subsampled to 5833 counts. 
After processing, 651760 high quality sequences were obtained in this study, with an average of 20651 sequences 
per sample. From these sequences, 6 known phyla and 30 genera were identified, and a total of 90 OTUs were 
detected at the 97% sequence identity threshold.
A rarefaction curve of the observed OTUs against sequences per sample was plotted for spit, drool and oral 
rinse to determine the efficiency of the sequencing process (Fig. 5). The Shannon index was determined for each 
sample, with the oral rinse samples having a consistently greater mean value (4.83) compared to spit and drool 
samples (4.79 and 4.77, respectively), although these differences were not statistically significant (Fig. 5). The 
β-diversity analyses showed no observable patterns among the spit, drool and oral rinse samples, the differences 
thereby primarily driven by the inter-subject variation rather than saliva fractions (Fig. 6).
Figure 2. Extracted salivary gDNA from different saliva collection methods. Scatter plots for the average 
quantity and quality of the extracted gDNA triplicates from each collection and extraction method (a., b. 
Maxwell® 16 LEV blood DNA kit; c., d. in-house phenol-chloroform extraction and e., f. QIAamp DNA 
Microbiome Kit).
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The taxonomic profiles of spit, drool and oral rinse samples were examined based on the proportion of bacte-
rial sequences determined at genus level (Supplementary Data 5). The five major genera found in all three saliva 
Figure 3. Extracted salivary gDNA from different bacterial gDNA extraction methods. Scatter plots for 
the average quantity and quality of the extracted gDNA triplicates from each collection (a., b. spit from 50 
mL Falcon tube and c., d. OMNIgene) and extraction (MW represents Maxwell® 16 LEV blood DNA kit; 
PC represents in-house phenol-chloroform extraction and QM represents QIAamp DNA Microbiome Kit) 












Maxwell® 16 LEV blood DNA kit
Average 16.48 28.35 22.51 29.81
Standard deviation 5.07 1.60 5.65 0.60
Standard error 1.60 0.51 1.79 0.19
In-house phenol-chloroform extraction
Average 12.80 26.39 14.22 26.43
Standard deviation 2.63 2.44 6.12 2.83
Standard error 0.83 0.77 1.94 0.89
QIAamp DNA Microbiome Kit
Average 14.83 27.47 15.89 27.26
Standard deviation 4.28 1.56 8.13 2.61
Standard error 1.35 0.49 2.57 0.83
Table 1. Bacterial 16S rRNA and human β-globin qPCR statistical summary for the extracted gDNA (for all 
three extraction methods).
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fractions were Streptococcus (17.5%), Prevotella (15.5%), Veillonella (15.3%), Neisseria (12.7%) and Haemophilus 
(10%). Calypso’s redundancy analysis was used to determine if combining the distribution pattern of all the 
genera from each saliva fraction into a panel could distinguish different saliva fractions (Fig. 7a). The p-value 
generated was 0.999, indicating that there are no significant differences. A second redundancy analysis under the 
same set of parameters was also carried out to investigate if the genera distribution of the three saliva fractions is 
distinguishable from one another (Fig. 7b). The results showed that the genera distributions from the three saliva 
fractions were significantly different for each individual with a p-value of 0.001, indicating the microbiome were 
more driven by host/environmental variations between subjects.
Figure 4. Extracted salivary gDNA from different saliva fractions. (a) Scatter plots for the quantity and quality 
of the extracted bacterial gDNA from each saliva fraction. Significant differences are denoted with *=p < 0.05, 
**=p < 0.01, ***=p < 0.001, ****=p < 0.0001 respectively. (b) Bacterial 16S rRNA and human β-globin qPCR 
Ct means distribution trend for the extracted gDNA from spit, drool and oral rinse.
Figure 5. Rarefaction curve for observed operational taxonomic units against sequences per sample for spit, 
drool and oral rinse.
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Discussion
Saliva harbours bacteria shed from adhering microbial communities on various intraoral surfaces26. It is also well 
established that the oral cavity is colonized by numerous and diverse microorganisms27. While bacterial gDNA 
extraction methods have been rigidly investigated in the past, there is a paucity of data and knowledge regarding 
the ideal saliva fraction to be used for microbial analysis of the oral cavity28–30. According to Lazarevic et al.28, 
mechanical lysis (repeated bead-beating) is critical for greater bacterial OTU richness in saliva samples due to the 
rigid bacterial cell walls. This was also confirmed by Sohrabi et al.29 in addition to the incorporation of enzymatic 
cell lysis (repeated bead-beating in lysis buffer) to increase the purity of extracted bacterial gDNA. In this study, 
we incorporated the enzymatic-mechanical lysis method with current bacterial gDNA extraction kits to investi-
gate the yield and quality of bacterial gDNA from different saliva fractions.
Our results demonstrate comparable quality and quantity of extracted gDNA from saliva samples when sam-
ples are either preserved using a stabilising buffer solution (OMNIgene) or when stored neat at −80 °C. In our 
hands, the Maxwell® 16 LEV Blood DNA kit with enzymatic-mechanical lysis provides the preferred method 
Figure 6. Beta-diversity of salivary microbiome. Weighted (a) and unweighted (b) PCoA plot for spit, drool 
and oral rinse samples with respective adjacent plots emphasizing on the subjects in different representing 
colours.
Figure 7. Salivary microbiome genera redundancy analysis on different (a) saliva fractions and (b) subjects.
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for isolating bacterial gDNA from saliva, in terms of gDNA yield, quality and ratio of bacterial:human gDNA. 
We have found also relatively higher α-diversity of OTUs in the oral rinse fraction as opposed to spit and drool, 
although these differences were not statistically significant.
Bacterial colonisation is apparent at many sites within the oral cavity, including the gingival, cervical line, 
tooth surface, tonsil, buccal mucosa, and tongue. As such it is important to develop a method that can access all of 
these sites and the diversity inherent to them27, 31, 32. Since microbes in the oral cavity travel via tongue and saliva 
movement, three saliva fractions were tested for microbial diversity via 16S rRNA gene amplicon sequencing31, 33. 
The main difference among these saliva fractions is that the muscle movements from spitting action may provide 
a larger microbial coverage compared with passive drooling; while oral rinse sampling provides access into the 
microbial populations residing within the oropharyngeal/throat area through the gargling action of the saline 
solution. The taxonomic profiles of the three saliva fractions were similar at genus-level and therefore can argua-
bly be used inter-changeably for down-stream applications. However, we recommend the oral rinse method as the 
saliva fraction of choice when possible for future studies due to a greater α-diversity in OTUs compared to drool 
and split considering the inclusion of oropharyngeal regions. Furthermore, it should also be pointed out that 
healthy volunteers were used in this study, but in our experience an oral rinse sample is ideal in people restricted 
in their ability to produce saliva, such as patients with xerostomia or cancer patients who have undergone chemo-
radiation treatment.
The bacterial profiles identified in our study corroborated with previous findings. Bik et al.34 investigated the 
oral microbiome of ten individuals with healthy oral tissues and gingiva (full-mouth clinical examinations were 
performed by certified dentists) in both men and women between the ages of 27 to 61 years34. Whole-mouth 
saliva samples and dental plaque specimens were collected and pooled to create a single ‘subgingival pool’ in 
this study34. Similarly, Ozga et al.35 examined the oral microbiome of 57 individuals (no selection criteria) from 
Oklahoma, United States35. Whole-mouth saliva samples were collected from both men and women between the 
ages of 23 to 70 years35. The oral microbiome profiles from both of these studies were determined by 16S rRNA 
gene amplicon sequencing34, 35. The result from our study bears a closer resemblance with findings from Bik et al.34  
probably due to the similarly stringent recruitment criteria used in subject selection34. In contrast, Ozga et al.35 
selected more lenient recruitment criteria that included subjects with smoking history, bad oral hygiene and 
active antibiotic use35. The microbial profiles produced from all three saliva fractions were comparable with the 
numerically predominant taxa included in both studies despite minor differences in abundance, indicating the 
reliability of our dataset.
Conclusion
Saliva sample collection, processing and gDNA preparation does not significantly influence the salivary microbi-
ome profiles provided that enzymatic-mechanical lysis has been incorporated into the bacterial gDNA extraction 
protocol. Based on our findings, saliva sampling for microbial research is fairly flexible compared to faecal sam-
ples. This allows for number of modifications based on the experimental set-up and down-stream application. 
However, to improve the purity of bacterial gDNA extracted from saliva samples, we found the Maxwell® 16 
LEV Blood DNA kit provided the optimal results. The lack of a coherent and comprehensive guideline in salivary 
microbiome study design might be a major driver for conflicting findings, a limit inter-study comparison derived 
from the published literature. We hope that our findings will contribute to those efforts to standardise the saliva 
collection and bacterial gDNA extraction protocol for future microbiome research.
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